Sheaff Brock Investment Advisors, LLC Alaunos Therapeutics, Inc. Transaction History

Sheaff Brock Investment Advisors, LLC

  • $1.58 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 28, 2019
SELL
$1.61 - $3.62 $23,316 - $52,424
-14,482 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$2.26 - $3.27 $5,649 - $8,175
2,500 Added 20.86%
14,482 $46,000
Q2 2017

Aug 09, 2017
BUY
N/A
11,982
11,982 $75,000

Others Institutions Holding TCRT

# of Institutions
8
Shares Held
106K
Call Options Held
0
Put Options Held
0
View Full List

About Alaunos Therapeutics, Inc.

TCRT Quotes by TradingView
  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $141M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email